Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 234 of 1,261

  1. US 11466055

    Virus-like nanoparticles for oral delivery

    The Regents of the University of California · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  2. US 11466018

    TGF-β inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  3. US 11466024

    Bicylic compound acting as an inhibitor

    Medshine Discovery Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  4. US 11466070

    Signalling system

    AUTOLUS LIMITED · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  5. US 11466028

    Fused 1,4-oxazepines as BET protein degraders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  6. US 11466261

    Mutated PTE enzymes

    Regents of the University of Minnesota · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  7. US 11465995

    Crystal and salt forms of tricyclic compound and preparation process thereof

    Medshine Discovery Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  8. US 11464788

    Oligomer-corticosteroid conjugates

    Nektar Therapeutics · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  9. US 11465972

    Inhibitors of oxidized low-density lipoprotein receptor 1 and methods of use thereof

    United States Government as represented by the Department of Veterans Affairs · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  10. US 11465976

    1,2,4-oxadiazole and thiadiazole compounds as immunomodulators

    Aurigene Discovery Technologies Limited · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  11. US 11465994

    MGluR7 agonist compounds for treating mGluR7-regulated diseases, disorders, or conditions

    Takeda Pharmaceutical Company Limited · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  12. US 11466015

    Crystalline forms of 8-(2-fluorobenzyl)-6-(3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl)imidazo[1,2-a]pyrazine as sGC stimulators

    Cyclerion Therapeutics, Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  13. US 11464830

    Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  14. US 11464843

    Use of the salmonella SPP type III secretion proteins as a protective vaccination

    The Board of Regents for Oklahoma State University · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  15. US 11464719

    Cosmetic and dermatological compositions

    Northwestern University · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  16. US 11464845

    Neisseria meningitidis immunogenic compositions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  17. US 11464856

    Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers

    Julius-Maximilians-Universitat Wurzburg · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  18. US 11465998

    Therapeutic compounds and methods of use thereof

    Regents of the University of Minnesota · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  19. US 11464869

    Non-adult human dosing of brentuximab vedotin

    Takeda Pharmaceutical Company Limited · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  20. US 11464807

    Genetically engineered hematopoietic stem cells and uses thereof

    Vor Biopharma Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  21. US 11466017

    Heterocyclic inhibitors of PTPN11

    The Board of Regents of the University of Texas System · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  22. US 11464784

    Inhibition of aminocylase 3 (AA3) in the treatment of cancer

    The Regents of the University of California · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  23. US 11464795

    Saponin compound targeting PD-1 and application thereof

    East China University of Science and Technology · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  24. US 11464802

    3-substituted piperidine compounds for Cbl-b inhibition, and use thereof

    NURIX THERAPEUTICS, INC. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.